JeffreyMarksMD

Obstetrics & Gynecology • Clearwater, FL

Physician

Join to view full profile

Are you Dr. Marks?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 63 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
2665 State Road 580
Clearwater, FL 33761
Phone+1 727-725-5121

Fax+1 727-725-5417
Is this information wrong?

Summary

Dr. Jeffrey Marks, MD is an obstetrician/gynecologist in Clearwater, Florida. He is currently licensed to practice medicine in Florida. He is affiliated with Mease Countryside Hospital.

Education & Training

University of South Florida MorsaniResidency, Obstetrics and Gynecology, 1984 - 1988
Case Western Reserve University School of MedicineClass of 1984

Certifications & Licensure

FL State Medical License 1987 - 2023

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2012-2014

Publications & Presentations

PubMed

LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition.
Hu, Q.,Li, C.,Wang, S.,Li, Y.,Wen, B.,Zhang, Y.,Liang, K.,Yao, J.,Ye, Y.,Hsiao, H.,Nguyen, T. K.,Park, P. K.,Egranov, S. D.,Hawke, D. H.,Marks, J. R.,Han, L.,Hung, M. ...> ;Cell Res.. 2019 Jan 12
HASH(0x39db5e8)
Sang, L. J.,Ju, H. Q.,Liu, G. P.,Tian, T.,Ma, G. L.,Lu, Y. X.,Liu, Z. X.,Pan, R. L.,Li, R. H.,Piao, H. L.,Marks, J. R.,Yang, L. J.,Yan, Q.,Wang, W.,Shao, J.,Zhou, Y.,Z...> ;Mol. Cell. 2018 Sep 18
CircIRAK3 sponges miR-3607 to facilitate breast cancer metastasis.
Wu, J.,Jiang, Z.,Chen, C.,Hu, Q.,Fu, Z.,Chen, J.,Wang, Z.,Wang, Q.,Li, A.,Marks, J. R.,Guo, C.,Chen, Y.,Zhou, J.,Yang, L.,Lin, C.,Wang, S.> ;Cancer Lett.. 2018 May 29
Intra-tumor molecular heterogeneity in breast cancer: definitions of measures and association with distant recurrence-free survival.
Saha, A.,Harowicz, M. R.,Cain, E. H.,Hall, A. H.,Hwang, E. S.,Marks, J. R.,Marcom, P. K.,Mazurowski, M. A.> ;Breast Cancer Res. Treat.. 2018 Jul 12
Prediction of Occult Invasive Disease in Ductal Carcinoma in Situ Using Deep Learning Features.
Shi, B.,Grimm, L. J.,Mazurowski, M. A.,Baker, J. A.,Marks, J. R.,King, L. M.,Maley, C. C.,Hwang, E. S.,Lo, J. Y.> ;J Am Coll Radiol. 2018 Feb 06
Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer.
Lawrenson, K.,Iversen, E. S.,Tyrer, J.,Weber, R. P.,Concannon, P.,Hazelett, D. J.,Li, Q.,Marks, J. R.,Berchuck, A.,Lee, J. M.,Aben, K. K.,Anton-Culver, H.,Antonenkova,...> ;Carcinogenesis. 2015 Oct 02
Prognostic significance of differential expression of angiogenic genes in women with high-grade serous ovarian carcinoma.
Siamakpour-Reihani S, Owzar K, Jiang C, Turner T, Deng Y, Bean SM, Horton JK, Berchuck A, Marks JR, Dewhirst MW, Alvarez Secord A> ;Gynecol. Oncol.. 2015-10-01
Porcine Abdominal Wall Simulator for Laparotomy Incision and Closure.
Khan S, Cipriano C, Marks JM, Schomisch SJ> ;Surg Innov. 2015-08-01
11 citations
Construction and Analysis of the NCI-EDRN Breast Cancer Reference Set for Circulating Markers of Disease
Jeffrey R. Marks, Karen S. Anderson, Paul F. Engstrom, Andrew K. Godwin, Laura J. Esserman, Gary Longton, Edwin S. Iversen, Anu Mathew, Christos Patriotis, Margaret S....> ;Cancer Epidemiology, Biomarkers & Prevention. 2015 Feb 1
Preliminary results of antiscarring therapy in the prevention of postendoscopic esophageal mucosectomy strictures.
Wu Y, Schomisch SJ, Cipriano C, Chak A, Lash RH, Ponsky JL, Marks JM> ;Surg Endosc. 2014-02-01
Commercially available biological mesh does not prevent stricture after esophageal mucosectomy.
Schomisch, S. J.,Yu, L.,Wu, Y.,Pauli, E. M.,Cipriano, C.,Chak, A.,Lash, R. H.,Ponsky, J. L.,Marks, J. M.> ;Endoscopy. 2013 Nov 13
Molecular signatures of epithelial ovarian cancer: analysis of associations with tumor characteristics and epidemiologic risk factors.
Schildkraut JM, Iversen ES, Akushevich L, Whitaker R, Bentley RC, Berchuck A, Marks JR> ;Cancer Epidemiol. Biomarkers Prev.. 2013-10-01
Single-incision laparoscopic cholecystectomy is associated with improved cosmesis scoring at the cost of significantly higher hernia rates: 1-year results of a prospec...
Marks, J. M.,Phillips, M. S.,Tacchino, R.,Roberts, K.,Onders, R.,DeNoto, G.,Gecelter, G.,Rubach, E.,Rivas, H.,Islam, A.,Soper, N.,Paraskeva, P.,Rosemurgy, A.,Ross, S.,...> ;J. Am. Coll. Surg.. 2013 Jun
Validation of Ovarian Cancer Gene Expression Signatures for Survival and Subtype in Formalin Fixed Paraffin Embedded Tissues
Gregory P Sfakianos, Susan K Murphy, Andrew Berchuck, Jeffrey R Marks> ;Gynecologic Oncology. 2013 Apr
Vitamin D receptor (VDR) polymorphisms and risk of ovarian cancer in Caucasian and African American women.
Grant DJ, Hoyo C, Akushevich L, Iversen ES, Whitaker R, Marks J, Berchuck A, Schildkraut JM> ;Gynecol. Oncol.. 2013-04-01
Biodegradable esophageal stent placement does not prevent high-grade stricture formation after circumferential mucosal resection in a porcine model.
Pauli EM, Schomisch SJ, Furlan JP, Marks AS, Chak A, Lash RH, Ponsky JL, Marks JM> ;Surg Endosc. 2012-12-01
Loss of ARID1A-associated protein expression is a frequent event in clear cell and endometrioid ovarian cancers.
Lowery WJ, Schildkraut JM, Akushevich L, Bentley R, Marks JR, Huntsman D, Berchuck A> ;Int. J. Gynecol. Cancer. 2012-01-01
Comparison of anterior transgastric access techniques for natural orifice translumenal endoscopic surgery.
Schomisch SJ, Furlan JP, Andrews JM, Trunzo JA, Ponsky JL, Marks JM> ;Surg Endosc. 2011-12-01
Plasma biomarker profiles differ depending on breast cancer subtype but RANTES is consistently increased.
Gonzalez RM, Daly DS, Tan R, Marks JR, Zangar RC> ;Cancer Epidemiol. Biomarkers Prev.. 2011-07-01
Development of an ovarian cancer screening decision model that incorporates disease heterogeneity: implications for potential mortality reduction.
Havrilesky LJ, Sanders GD, Kulasingam S, Chino JP, Berchuck A, Marks JR, Myers ER> ;Cancer. 2011-02-01
A feasibility and dosimetric evaluation of endoscopic radiofrequency ablation for human colonic and rectal epithelium in a treat and resect trial.
Trunzo JA, McGee MF, Poulose BK, Willis JE, Ermlich B, Laughinghouse M, Champagne BJ, Delaney CP, Marks JM> ;Surg Endosc. 2011-02-01
Individual responses to chemotherapy-induced oxidative stress.
Il'yasova D, Kennedy K, Spasojevic I, Wang F, Tolun AA, Base K, Young SP, Kelly Marcom P, Marks J, Millington DS, Dewhirst MW> ;Breast Cancer Res. Treat.. 2011-01-01
Retraction: Genomic signatures to guide the use of chemotherapeutics.
Potti A, Dressman HK, Bild A, Riedel RF, Chan G, Sayer R, Cragun J, Cottrill H, Kelley MJ, Petersen R, Harpole D, Marks J, Berchuck A, Ginsburg GS, Febbo P, Lancaster ...> ;Nat. Med.. 2011-01-01
Severe obesity is associated with symptomatic presentation, higher parathyroid hormone levels, and increased gland weight in primary hyperparathyroidism.
Adam MA, Untch BR, Danko ME, Stinnett S, Dixit D, Koh J, Marks JR, Olson JA> ;J. Clin. Endocrinol. Metab.. 2010-11-01
Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis.
Moorman PG, Iversen ES, Marcom PK, Marks JR, Wang F, Lee E, Ursin G, Rebbeck TR, Domchek SM, Arun B, Susswein L, Isaacs C, Garber JE, Visvanathan K, Griffin CA, Sutphe...> ;Breast Cancer Res. Treat.. 2010-11-01
Join now to see all

Hospital Affiliations

Mease Countryside HospitalSafety Harbor, Florida
Plantation General HospitalFort Lauderdale, Florida